...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Biotech Showcase 2017 Slides

Didn't see anything new in the Zenith slide deck; however, there was new stuff related to the proteomic analysis of the CKD study in the Resverlogix slide deck (slides 19-22).

Share
New Message
Please login to post a reply